Abstract:Background: Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency (HMGCS2D) is a rare autosomal recessive metabolic disorder caused by mutations of the HMGCS2 gene. To date, no more than 60 patients have been reported throughout the world.Purpose: To analyze the clinical, biochemical, molecular, and outcome features of HMGCS2D in a case series of 10 new Chinese patients.Methods: This retrospective study includes 10 Chinese patients diagnosed with HMGCS2D. We collected and analyzed clinical data for all patients. We also reviewed clinical data for 39 cases that had been reported previously.Results: All of our patients had experienced their first metabolic crisis before 12 months old. The most common clinical manifestations were anorexia, dyspnea, and disturbance of consciousness (10/10), followed by vomiting (8/10), fever (7/10), cough (4/10), diarrhea, and seizures (3/10). Each patient (10/10) had a different degree of hepatomegaly and increased aminotransferase, severe metabolic acidosis, and hypofibrinogenemia. 9 patients presented with severe hypoglycemia and weak positives on qualitative tests of urinary ketone body. Patient 3 was the only one without hypoglycemia. Five patients had hypocalcemia, five patients had hyperammonemia, four patients had hyperuricemia, and three had hypertriglyceridemia. During the metabolic acidosis episode, we observed high dicarboxylic acid values in urine, and the elevated ratio of blood acetylcarnitine to free carnitine may have been an additional biochemical signature. However, all returned to normal during the interictal interval. Molecular analysis identified 15 variants in the HMGCS2 gene, of which 10 were novel (c.220G>A/p.E74K, c.407A>G/p.D136G, c.422T>A/p.V141D, c.719A>C/p.D240A, c.821G>A/p.R274H, c.39dupA/p.L14Tfs*59, c.1394delA/p.N465Tfs*10, c.788delT/p.L263Cfs*36, c.717T>G/p.Y239*, and c.1017-2A>G). Combining these with previous cases, the known mutation c.1201G>T/p.E401* has been found in 6/40 (15.0%) of mutated alleles in 21 Chinese patients from 20 families, while none have been found in other populations. We found that patients with biallelic truncation mutation appeared to show a more severe clinical condition through a literature review.Conclusion: This study analyzed the phenotypic and genetic features of HMGCS2D in a Chinese case series. We also expanded the HMGCS2 mutational spectrum with 10 novel variants. The c.1201G>T/p.E401* mutation was the most frequent, representing 15.0% of the mutated alleles in reported unrelated Chinese patients, and thus, it may be a hot spot mutation.

Fourteen Cases of Cerebral Creatine Deficiency Syndrome in Children: a Cohort Study in China.

[Genetic Analysis and Treatment for an Infant with Cerebral Creatine Deficiency Syndrome Type 2].

Long-term Follow-Up of Children with Carbamoyl Phosphate Synthase 1 Deficiency Detected in Newborn Screening.

[Clinical and Genetic Analysis of a Child with Cerebral Creatine Deficiency Syndrome Due to Variant of SLC6A8 Gene].

[Clinical Features and SLC6A8 Gene Mutations of Cerebral Creatine Deficiency Syndrome I: an Analysis of Two Families].

Response to therapy of creatine transporter deficiency caused by a hypomorphic variant in SLC6A8

First Reported Chinese Case of Guanidinoacetate Methyltransferase Deficiency in a 4-Year-old Child.

Creatine Transporter Deficiency Presenting as Failure to Thrive: A Case Report of a Novel SLC6A8 Variant Causing a Treatable but Likely Underdiagnosed Genetic Disorder

Identification of novel variations in SLC6A8 and GAMT genes causing cerebral creatine deficiency syndrome

X-linked creatine transporter (SLC6A8) deficiency in females: Difficult to recognize, but a potentially treatable disease

Novel KRIT1/CCM1 and MGC4607/CCM2 Gene Variants in Chinese Families with Cerebral Cavernous Malformations

Easily Misdiagnosed cblC Deficiency in Adolescents: the Clinical and Metabolic Studies

1H MR spectroscopy as a diagnostic tool for cerebral creatine deficiency

The First Case of Cobalamin F Disorder in China: Report and Literature Review

Case Report: Rapid Treatment of Uridine-Responsive Epileptic Encephalopathy Caused by CAD Deficiency

Connectomic and behavioral alterations in creatine transporter deficiency are partially normalized by gene therapy

Late-onset Cblc Deficiency Around Puberty: a Retrospective Study of the Clinical Characteristics, Diagnosis, and Treatment

ClinGen variant curation expert panel recommendations for classification of variants in GAMT, GATM and SLC6A8 for cerebral creatine deficiency syndromes

Gene Mutation Analysis in 12 Chinese Children with Congenital Nephrotic Syndrome.

The Phenotypic and Genotypic Spectrum of CSF1R‐Related Disorder in China

Clinical, Biochemical, Molecular, and Outcome Features of Mitochondrial 3-Hydroxy-3-methylglutaryl-coa Synthase Deficiency in 10 Chinese Patients